DexCom Hold Rating with A Growth Score Forecasts 19.1% Earnings Rise
DexCom holds a #3 Hold rating with a B VGM Score and an A Growth Score forecasting 19.1% earnings growth this year. Seven analysts lifted its 2026 EPS forecast by $0.02 to $2.49, and the company has averaged a 3.8% earnings surprise.
1. DexCom Ratings Overview
DexCom holds a #3 Hold rating with a B VGM Score and an A Growth Score. The Growth Score forecasts 19.1% year-over-year earnings growth for fiscal 2026 based on projected sales and cash flow improvements.
2. Analyst Estimate Revisions
In the past 60 days, seven analysts have increased their fiscal 2026 EPS forecasts by a combined $0.02, bringing the consensus estimate to $2.49 per share. Upward revisions reflect stronger-than-expected demand and production efficiencies.
3. Earnings Surprise History
DexCom has delivered an average earnings surprise of +3.8% over recent quarters, indicating consistent outperformance versus analyst estimates. This track record may support continued upward momentum in estimate revisions and investor confidence.